ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma.

"Declarations Ethics approval and consent to participateThis study was approved by the Fudan University Shanghai Cancer Center Research Ethics Committee, and all individuals provided informed consent for inclusion of their tissue in this study. Moreover, animal study was approved by the Animal Experimentation Ethics Committee of Shanghai Cancer Center, Fudan University. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Lu Ren-Quan was sponsored by National Natural Science Foundation of China (81772774, 82072876); Program of scientific and technological innovation action plan, Shanghai Municipal Commission of science and technology (20XD1434200, 20Y11903500). Guo Lin was sponsored by National Natural Science Foundation of China (81772808). Ma Xiao-Lu was sponsored by Shanghai Sailing Program (20YF1407900); National Natural Science Foundation of China (82002618). Wang Yan-Chun was sponsored by National Natural Science Foundation of China (81800190). Zheng Hui was sponsored by Shanghai Natural Science Foundation, Shanghai Municipal Commission of science and technology (19ZR1410300)."